Workflow
Cell-based solutions
icon
Search documents
Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year
Globenewswire· 2025-11-13 13:00
Core Insights - Pluri Inc. has received multiple awards recognizing its innovation and leadership in biotechnology, particularly in cell-based solutions for agriculture and sustainable food systems [1][2][4] Group 1: Awards and Recognitions - Pluri was named Overall BioAgriculture Company of the Year by the Biotech Breakthrough Awards, highlighting its advancements in applying cell therapy to agriculture [2] - The company won the 2024 Egalitarian Employment Award in the Large Company category from Israel's Ministry of Labor, Social Affairs and Social Services, with a government grant of 40,000 NIS expected alongside the award [3] - Pluri's subsidiaries, Coffeesai Ltd. and Kokomodo Ltd., received significant industry awards for their innovative approaches in sustainable food production and climate-resilient agriculture [7] Group 2: Company Position and Strategy - Pluri is positioned as a leader in biotechnology, developing patented technologies that have the potential to transform various industries, including regenerative medicine and agtech [4] - The company's proprietary 3D cell expansion platform enables scalable production of cell-based products, facilitating partnerships in multiple sectors [4][5] - The CEO emphasized the strength and versatility of Pluri's platform, reflecting market confidence in its strategy to apply cell-based innovation across industries [5]
Pluri Subsidiary Coffeesai and Instituto del Café de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico
Globenewswire· 2025-10-08 13:00
Core Insights - Pluri Inc. has announced a collaboration with Instituto del Café de Chiapas to advance cell-based coffee manufacturing in Mexico, leveraging its subsidiary Coffeesai's technology [1][2][4] Group 1: Collaboration and Strategy - The collaboration aims to establish Chiapas as a hub for cell-based coffee innovation, combining biotechnology with local coffee traditions [2][4] - The partnership is structured around a three-phase roadmap to de-risk commercialization, starting with cell line development and moving towards pilot-scale biofarming and commercial-scale manufacturing [5][6] Group 2: Market Potential and Financial Outlook - The global coffee market exceeded $250 billion in 2024 and is projected to surpass $350 billion by 2030, indicating a significant opportunity for scalable production [5] - The collaboration is expected to create a revenue-generating model aligned with shareholder interests while transforming the future of coffee production [4][5] Group 3: Technological Innovation - Coffeesai will utilize Pluri's proprietary 3D cell expansion platform to develop sustainable coffee solutions that are resilient to climate change and market volatility [5][8] - The innovative process aims to eliminate the negative environmental impacts associated with traditional coffee farming, ensuring consistent quality and high yields [8]